Header

UZH-Logo

Maintenance Infos

Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections


Baumann, Philipp; Baer, Gurli; Bonhoeffer, Jessica; Fuchs, Aline; Gotta, Verena; Heininger, Ulrich; Ritz, Nicole; Szinnai, Gabor; Bonhoeffer, Jan (2017). Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections. Frontiers in Pediatrics, 5:183.

Abstract

Mortality and morbidity remain high in pediatric lower respiratory tract infections (LRTIs) despite progress in research and implementation of global diagnostic and treatment strategies in the last decade. Still, 120 million annual episodes of pneumonia affect children younger than 5 years each year leading to 1.3 million fatalities with the major burden of disease carried by low- and middle-income countries (95%). The definition of pneumonia is still challenging. Traditional diagnostic measures (i.e., chest radiographs, C-reactive protein) are unable to distinguish viral and from bacterial etiology. As a result, common antibiotic overuse contributes to growing antibiotic resistance. We present an overview of current evidence from observational and randomized controlled trials on a procalcitonin (PCT)-based diagnosis of pediatric LRTIs and discuss the need for an adequate PCT threshold for antibiotic treatment decision-making.

Abstract

Mortality and morbidity remain high in pediatric lower respiratory tract infections (LRTIs) despite progress in research and implementation of global diagnostic and treatment strategies in the last decade. Still, 120 million annual episodes of pneumonia affect children younger than 5 years each year leading to 1.3 million fatalities with the major burden of disease carried by low- and middle-income countries (95%). The definition of pneumonia is still challenging. Traditional diagnostic measures (i.e., chest radiographs, C-reactive protein) are unable to distinguish viral and from bacterial etiology. As a result, common antibiotic overuse contributes to growing antibiotic resistance. We present an overview of current evidence from observational and randomized controlled trials on a procalcitonin (PCT)-based diagnosis of pediatric LRTIs and discuss the need for an adequate PCT threshold for antibiotic treatment decision-making.

Statistics

Citations

Dimensions.ai Metrics
6 citations in Web of Science®
8 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

35 downloads since deposited on 08 Feb 2018
11 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Pediatrics, Perinatology and Child Health
Language:English
Date:2017
Deposited On:08 Feb 2018 10:15
Last Modified:08 Jul 2020 10:04
Publisher:Frontiers Research Foundation
ISSN:2296-2360
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.3389/fped.2017.00183
Related URLs:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581362/
PubMed ID:28894729
Other Identification Number:PMCID: PMC5581362

Download

Gold Open Access

Download PDF  'Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections'.
Preview
Content: Published Version
Filetype: PDF
Size: 134kB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)